相关实验视频

Updated: Jul 27, 2026

Improved Visualization of Lung Metastases at Single Cell Resolution in Mice by Combined In-situ Perfusion of Lung Tissue and X-Gal Staining of lacZ-Tagged Tumor Cells

Improved Visualization of Lung Metastases at Single Cell Resolution in Mice by Combined In-situ Perfusion of Lung Tissue and X-Gal Staining of lacZ-Tagged Tumor Cells

Published on: August 21, 2012

甲福明可以防止骨质细胞样潜力和肺癌A549细胞中的化

Pooja Yadav¹, Sweta Makwana¹, Shivani Bansal¹

¹Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.

Journal of biochemical and molecular toxicology

|July 6, 2023

概括

肺癌细胞表现出类似骨质母细胞的潜力,导致化. 抗糖尿病药物甲福明可以通过抑制骨形态遗传蛋白-2 (BMP-2) 诱导的变化和上皮转化为介质酶转化 (EMT) 来预防这种情况.

科学领域:

在瘤学瘤学.
细胞生物学细胞生物学
生物矿物化生物矿物化

背景情况:

癌症仍然是全球主要的死亡原因,具有不同的分子机制.
在包括肺癌在内的各种癌症中观察到病态矿化或化.
众所周知,骨质母细胞类细胞,通常来自中介质干细胞,驱动沉积.

研究的目的:

为了调查肺癌细胞中骨质母细胞类潜能的存在.
探索驱动肺癌中化的机制.
确定肺癌化的潜在预防策略.

主要方法:

在A549肺癌细胞上进行了实验.
测试包括ALP活性,ALP染色,结节形成,RT-PCR,RT-qPCR和西部斑分析.
分析了骨质细胞标记物和骨质诱导基因的基因和蛋白质表达.

主要成果:

A549细胞表现出类似骨质细胞的潜力,ALP活动和结节形成证明了这一点.
检测到骨质细胞标记物 (ALP,OPN,RUNX2,Osterix) 和骨质诱导基因 (BMP-2,BMP-4) 的表达.
BMP-2治疗增强了骨质细胞样特征和化,而甲胺抑制了这些效应和BMP-2诱导的表皮转移到介质细胞转变 (EMT).

结论:

肺癌细胞 (A549) 具有类似骨质母细胞的潜力,有助于癌症化.
在肺癌细胞中,BMP-2信号传递促进了这种骨质母细胞类的表型和EMT.
甲胺在预防BMP-2诱导的骨质母细胞类表型和EMT方面表现出潜力,从而抑制肺癌化.

关键词:

美国BMP-2战斗机.性酸酶活性 (ALP) 的研究.石灰化是指化.肺癌是一种肺癌.甲胺是一种甲胺.骨质母细胞类似的潜在潜力.

更多相关视频

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

相关概念视频

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...